Cargando…

Gameplay as a Source of Intrinsic Motivation in a Randomized Controlled Trial of Auditory Training for Tinnitus

BACKGROUND: Previous studies of frequency discrimination training (FDT) for tinnitus used repetitive task-based training programmes relying on extrinsic factors to motivate participation. Studies reported limited improvement in tinnitus symptoms. PURPOSE: To evaluate FDT exploiting intrinsic motivat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoare, Derek J., Van Labeke, Nicolas, McCormack, Abby, Sereda, Magdalena, Smith, Sandra, Taher, Hala Al, Kowalkowski, Victoria L., Sharples, Mike, Hall, Deborah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162598/
https://www.ncbi.nlm.nih.gov/pubmed/25215617
http://dx.doi.org/10.1371/journal.pone.0107430
Descripción
Sumario:BACKGROUND: Previous studies of frequency discrimination training (FDT) for tinnitus used repetitive task-based training programmes relying on extrinsic factors to motivate participation. Studies reported limited improvement in tinnitus symptoms. PURPOSE: To evaluate FDT exploiting intrinsic motivations by integrating training with computer-gameplay. METHODS: Sixty participants were randomly assigned to train on either a conventional task-based training, or one of two interactive game-based training platforms over six weeks. Outcomes included assessment of motivation, tinnitus handicap, and performance on tests of attention. RESULTS: Participants reported greater intrinsic motivation to train on the interactive game-based platforms, yet compliance of all three groups was similar (∼70%) and changes in self-reported tinnitus severity were not significant. There was no difference between groups in terms of change in tinnitus severity or performance on measures of attention. CONCLUSION: FDT can be integrated within an intrinsically motivating game. Whilst this may improve participant experience, in this instance it did not translate to additional compliance or therapeutic benefit. TRIAL REGISTRATION: ClinicalTrials.gov NCT02095262